Dupixent
Overview
Dupixent is a biologic from the Sanofi-Regeneron collaboration, cited as an early manufacturing-and-partnership bet. Dupixent, from the Sanofi-Regeneron collaboration, was an early manufacturing and partnership bet that a novel biologic could be produced at global scale with consistency before demand was fully visible.
Sign in to read the full article.
Sign In